middle.news
How Will Firebrick’s New Innorini Deal Transform Nasodine’s Asian Market Reach?
11:04pm on Friday 29th of August, 2025 AEST
•
Pharmaceuticals
Read Story
How Will Firebrick’s New Innorini Deal Transform Nasodine’s Asian Market Reach?
11:04pm on Friday 29th of August, 2025 AEST
Key Points
Exclusive license granted to Innorini for four countries
Innorini assumes all marketing costs from 2026
Manufacturing rights included to enhance supply flexibility
Two-year term with renewal options
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Firebrick Pharma (ASX:FRE)
OPEN ARTICLE